Commonwealth Equity Services’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$140K Sell
18,167
-42
-0.2% -$306 ﹤0.01% 4084
2025
Q4
$112K Sell
18,209
-3,189
-15% -$34.4K ﹤0.01% 4096
2025
Q3
$394K Buy
21,398
+791
+4% +$12.7K ﹤0.01% 3379
2025
Q2
$268K Buy
20,607
+3,638
+21% +$43K ﹤0.01% 3695
2025
Q1
$180K Buy
16,969
+353
+2% +$5.6K ﹤0.01% 3870
2024
Q4
$282K Sell
16,616
-2,039
-11% -$38.4K ﹤0.01% 3465
2024
Q3
$433K Buy
18,655
+4,234
+29% +$90.6K ﹤0.01% 3010
2024
Q2
$351K Buy
14,421
+328
+2% +$9.95K ﹤0.01% 3162
2024
Q1
$476K Buy
14,093
+631
+5% +$22.4K ﹤0.01% 2858
2023
Q4
$424K Sell
13,462
-1,277
-9% -$30.4K ﹤0.01% 2874
2023
Q3
$377K Buy
14,739
+3,200
+28% +$98.6K ﹤0.01% 2830
2023
Q2
$331K Buy
11,539
+1,100
+11% +$29.9K ﹤0.01% 2963
2023
Q1
$250 Buy
10,439
+299
+3% +$5.36K ﹤0.01% 3118
2022
Q4
$171K Hold
10,140
﹤0.01% 3288
2022
Q3
$150K Sell
10,140
-587
-5% -$9.85K ﹤0.01% 3282
2022
Q2
$168K Sell
10,727
-25
-0.2% -$491 ﹤0.01% 3256
2022
Q1
$289K Sell
10,752
-420
-4% -$10.7K ﹤0.01% 3003
2021
Q4
$413K Buy
11,172
+218
+2% +$8.88K ﹤0.01% 2689
2021
Q3
$523K Sell
10,954
-653
-6% -$29.3K ﹤0.01% 2442
2021
Q2
$392K Buy
11,607
+1,758
+18% +$59.5K ﹤0.01% 2665
2021
Q1
$406K Buy
9,849
+974
+11% +$58.1K ﹤0.01% 2487
2020
Q4
$385K Buy
8,875
+3,479
+64% +$236K ﹤0.01% 2344
2020
Q3
$231K Buy
5,396
+935
+21% +$46.4K ﹤0.01% 2589
2020
Q2
$208K Buy
+4,461
New +$154K ﹤0.01% 2562

Other funds holding ARCT